Last updated: April 22, 2026

Application No. 19/207,227

Untitled Application

Unknown

Filed

1600

Priority

Jan 12, 2017 — GB 1700555.4 +4 more

Examiner

POHNERT, STEVEN C

Art Unit

1683

Tech Center

Revolo Biotherapeutics Limited

Assignee

Revolo Biotherapeutics Limited

OA Round

1 (Non-Final)

This examiner grants 12% of cases after interview

— +18.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 857 resolved cases, 2023–2026

Examiner Intelligence

POHNERT, STEVEN C View full profile →

Grants only 12% of cases

Career Allowance Rate

104 granted / 857 resolved

-47.9% vs TC avg

Strong +18% interview lift

Without

With

+18.3%

Interview Lift

resolved cases with interview

Typical timeline

4y 2m

Avg Prosecution

45 currently pending

Career history

902

Total Applications

across all art units

Statute-Specific Performance

§101

16.5%

-23.5% vs TC avg

§103

30.3%

-9.7% vs TC avg

§102

11.6%

-28.4% vs TC avg

§112

32.9%

-7.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 857 resolved cases

Prosecution Timeline

1600

Application Filed

Mar 04, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/922,962

Patent 12577586

CROSS-SPECIES COMPATIBLE ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF

3y 4m to grant Granted Mar 17, 2026

16/896,118

Patent 12559788

Multiple Beads Per Droplet Resolution

5y 8m to grant Granted Feb 24, 2026

17/816,988

Patent 12460251

STABILIZATION AND/OR COMPACTION OF NUCLEIC ACID MOLECULES

3y 3m to grant Granted Nov 04, 2025

17/816,985

Patent 12391984

COMPOSITIONS AND METHODS FOR ROLLING CIRCLE AMPLIFICATION

3y 0m to grant Granted Aug 19, 2025

16/379,260

Patent 12286675

Epigentic Markers for the Identification of Blood Sub-cells of Type 1

6y 0m to grant Granted Apr 29, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

12%

Grant Probability

30%

With Interview (+18.3%)

4y 2m

Median Time to Grant

Low

PTA Risk

Based on 857 resolved cases by this examiner. Grant probability derived from career allowance rate.